TA129: Multiple myeloma - bortezomib
This is a discussion on TA129: Multiple myeloma - bortezomib within the Updates from the Technology Assessment Authorities forum, part of the Industry News and Updates category; The summary for the published technology appraisal on Multiple myeloma - bortezomib. It links to the published guidance and key documents. ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
04-01-2010, 12:51 PM
|
|||
|
|||
TA129: Multiple myeloma - bortezomib
The summary for the published technology appraisal on Multiple myeloma - bortezomib. It links to the published guidance and key documents.
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| TA171: Multiple myeloma - lenalidomide | industry_news | Updates from the Technology Assessment Authorities | 0 | 04-01-2010 12:51 PM |
| TA171: Multiple myeloma - lenalidomide | industry_news | Updates from the Technology Assessment Authorities | 0 | 06-17-2009 08:35 PM |
| Management of Multiple Myeloma Reviewed | industry_news | Other Clinical Pharmacy News | 0 | 10-13-2008 06:18 PM |
| Bortezomib Improves Outcomes in Initial Treatment of Myeloma | industry_news | Other Clinical Pharmacy News | 0 | 08-28-2008 03:12 PM |
| Thalomid approval for multiple myeloma | participant1 | Managed Care Issues for Oral Drugs | 1 | 02-21-2008 05:45 PM |
© 2008 DrugManagementForum™ powered by |
 |